J. Treuner

3.3k total citations
80 papers, 2.1k citations indexed

About

J. Treuner is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Surgery. According to data from OpenAlex, J. Treuner has authored 80 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 32 papers in Neurology and 21 papers in Surgery. Recurrent topics in J. Treuner's work include Neuroblastoma Research and Treatments (31 papers), Sarcoma Diagnosis and Treatment (30 papers) and Cancer, Hypoxia, and Metabolism (13 papers). J. Treuner is often cited by papers focused on Neuroblastoma Research and Treatments (31 papers), Sarcoma Diagnosis and Treatment (30 papers) and Cancer, Hypoxia, and Metabolism (13 papers). J. Treuner collaborates with scholars based in Germany, Austria and Italy. J. Treuner's co-authors include D. Harms, D. Niethammer, K. Winkler, H. Jürgens, R. Kotz, U. Göbel, St. Müller-Weihrich, U. Feine, D. Schmidt and Stefan Bielack and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

J. Treuner

78 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. Treuner 1.3k 527 499 493 475 80 2.1k
J. Miser 1.4k 1.1× 366 0.7× 505 1.0× 584 1.2× 410 0.9× 37 2.3k
J. Treuner 1.0k 0.8× 373 0.7× 314 0.6× 533 1.1× 341 0.7× 47 1.7k
Yutaka Daimaru 1.2k 1.0× 545 1.0× 788 1.6× 615 1.2× 671 1.4× 43 2.4k
Jörn Treuner 2.0k 1.6× 610 1.2× 649 1.3× 458 0.9× 623 1.3× 44 2.7k
Cynthia Kosloff 1.6k 1.2× 619 1.2× 688 1.4× 379 0.8× 785 1.7× 19 2.7k
M Brunat-Mentigny 1.0k 0.8× 636 1.2× 307 0.6× 581 1.2× 426 0.9× 96 2.1k
Ala B. Hamoudi 1.0k 0.8× 670 1.3× 508 1.0× 725 1.5× 550 1.2× 36 2.4k
John J. Brooks 897 0.7× 725 1.4× 358 0.7× 199 0.4× 397 0.8× 53 2.1k
Yasuo Beppu 1.5k 1.2× 341 0.6× 681 1.4× 190 0.4× 376 0.8× 76 2.2k
Vito Ninfo 1.3k 1.0× 599 1.1× 724 1.5× 162 0.3× 691 1.5× 73 2.3k

Countries citing papers authored by J. Treuner

Since Specialization
Citations

This map shows the geographic impact of J. Treuner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Treuner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Treuner more than expected).

Fields of papers citing papers by J. Treuner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Treuner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Treuner. The network helps show where J. Treuner may publish in the future.

Co-authorship network of co-authors of J. Treuner

This figure shows the co-authorship network connecting the top 25 collaborators of J. Treuner. A scholar is included among the top collaborators of J. Treuner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Treuner. J. Treuner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stöhr, Wolfgang, Marios Paulides, Stefan Bielack, et al.. (2006). Ifosfamide‐induced nephrotoxicity in 593 sarcoma patients: A report from the Late Effects Surveillance System. Pediatric Blood & Cancer. 48(4). 447–452. 76 indexed citations
2.
Schilling, Freimut H., Frank Berthold, R. Erttmann, et al.. (2000). Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results. Medical and Pediatric Oncology. 35(6). 701–704. 7 indexed citations
3.
Koscielniak, E., Gianantonio Rosti, J. Treuner, et al.. (1998). Prognosis in patients with primary bone and/or bone marrow metastases(MET) of rhabdomyosarcoma (RMS). A joint report of the EBMT solid tumor working party and the German soft tissue sarcoma study (CWS).. Bone Marrow Transplantation. 21.
4.
Erttmann, R., et al.. (1995). Neuroblastom-Früherkennung in Deutschland. Oncology Research and Treatment. 18(3). 28–32. 1 indexed citations
5.
Treuner, J. & Mary Morgan. (1995). Clinical Management of Soft Tissue Sarcomas. Current topics in pathology. 89. 17–30. 2 indexed citations
6.
Paulussen, Michael, Gabriele Braun‐Munzinger, S. Burdach, et al.. (1993). Behandlungsergebnisse beim primär ausschließlich pulmonal metastasierten Ewingsarkom. Klinische Pädiatrie. 205(4). 210–216. 19 indexed citations
7.
Cavazzana, Andrea, D. Schmidt, Vito Ninfo, et al.. (1992). Spindle Cell Rhabdomyosarcoma. The American Journal of Surgical Pathology. 16(3). 229–235. 164 indexed citations
8.
Handgretinger, Rupert, Gernot Bruchelt, Astrid Kimmig, et al.. (1990). In Vitro and In Vivo Effect of Interleukin-2 on the 2′,5′-Oligoadenylate Synthetase Activity of Peripheral Mononuclear Blood Cells. Journal of Interferon Research. 10(1). 75–82. 4 indexed citations
9.
Berthold, Frank, S. Burdach, Bernhard Kremens, et al.. (1990). The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience. Klinische Pädiatrie. 202(4). 262–269. 40 indexed citations
10.
Bruchelt, Gernot, F. Lohmann, Michael Teufel, et al.. (1990). Vasoactive intestinal polypeptide (VIP) induces calcium mobilization in the human neuroblastoma cell line SK-N-SH. Cancer Letters. 50(3). 203–207. 9 indexed citations
11.
Schilbach, Karin, Peter Pollwein, M. Schwab, et al.. (1990). Reduction of N-myc expression by antisense RNA is amplified by interferon: Possible involvement of the 2-5A system. Biochemical and Biophysical Research Communications. 170(3). 1242–1248. 7 indexed citations
12.
Treuner, J., et al.. (1989). The Predictive Value of Initial Cytostatic Response in Primary Unresectable Rhabdomyosarcoma in Children. Acta Oncologica. 28(1). 67–72. 13 indexed citations
13.
Klingebiel, Thomas, J. Treuner, Gerhard Ehninger, et al.. (1989). [131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Cancer Chemotherapy and Pharmacology. 25(2). 143–148. 20 indexed citations
14.
Treuner, J., et al.. (1989). Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas. Cancer Chemotherapy and Pharmacology. 24(S1). S48–50. 21 indexed citations
15.
Treuner, J., Joachim Kühl, Jörn‐Dirk Beck, et al.. (1989). New Aspects in the Treatment of Childhood Rhabdomyosarcoma: Results of the German Cooperative Soft-Tissue Sarcoma Study (CWS-81). PubMed. 22. 162–175. 8 indexed citations
16.
Bruchelt, Gernot, et al.. (1989). Cytotoxic Effects of 6-Hydroxydopamine, Merocyanine-540 and Related Compounds on Human Neuroblastoma-and Hematopoietic Stem Cells. Free Radical Research Communications. 7(3-6). 205–212. 5 indexed citations
17.
Koscielniak, E., J. Treuner, Modesto Carli, et al.. (1988). Rapid High-Dose Intensity Chemotherapy Including High-Dose Melphalan (Hdm) for Rhabdomyosarcoma. Medical and Pediatric Oncology. 16(6). 430–430. 1 indexed citations
18.
Handgretinger, Rupert, Gernot Bruchelt, Matthias Schneider, D. Niethammer, & J. Treuner. (1987). Application of Interleukin 2 in Neuroblastoma. Hämatologie und Bluttransfusion. 31. 116–119. 2 indexed citations
19.
20.
Treuner, J., et al.. (1981). Pharmacological Aspects of Clinical Stage 1/ II Trials with Human Beta Interferon in Children. Journal of Interferon Research. 1(3). 373–380. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Miser Breakdown of academic impact, for papers by J. Treuner Breakdown of academic impact, for papers by Yutaka Daimaru Breakdown of academic impact, for papers by Jörn Treuner Breakdown of academic impact, for papers by Cynthia Kosloff Breakdown of academic impact, for papers by M Brunat-Mentigny Breakdown of academic impact, for papers by Ala B. Hamoudi Breakdown of academic impact, for papers by John J. Brooks Breakdown of academic impact, for papers by Yasuo Beppu Breakdown of academic impact, for papers by Vito Ninfo
Rankless by CCL
2026